Chester County News and Community Website
YARDLEY, PA — Optinose (NASDAQ: OPTN), a specialty pharmaceutical company, announced today that its management team is slated to provide a comprehensive overview and update on the company’s business operations …
Optinose to Present at Needham Virtual Healthcare Conference Read More
CHESTERBROOK, PA — Trevena, Inc. (Nasdaq: TRVN), a leading pharmaceutical company, has recently unveiled its financial outcomes for the closing quarter of 2023, amidst a pivotal shift in their corporate …
Trevena Ramps Up Efforts on TRV045, Turns Attention Away from OLINVYK Amid Challenging Hospital Environment Read More
RADNOR, PA — Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a leader in developing treatments for rare genetic epilepsies and refractory seizure disorders, is currently embroiled in a legal battle to protect …
Marinus Pharmaceuticals Stands Firm in Patent Dispute Over Key Epilepsy Treatment Read More
BERWYN, PA — Recent developments have been flourishing for Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX). The Pennsylvania-based pharmaceutical innovator recently unveiled its financial records for 2023 and shared a series of …
Virpax Pharmaceuticals Set for Transformative Year with High Hopes for Non-Addictive Pain Management Solutions Read More
EXTON, PA — In a strategic move poised to reshape the pharmaceutical landscape, Japan’s EPNextS Group and US-based Frontage Laboratories, Inc. have announced a partnership aimed squarely at overcoming Japan’s …
EPNextS Group and Frontage Laboratories Forge Alliance to Tackle Japan’s Drug Development Hurdles Read More
MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX), a key player in the pharmaceutical industry, recently unveiled its financial results for the fourth quarter and full year of 2023, which …
Galera Therapeutics Seeks Strategic Alternatives Amid Financial Setbacks and Regulatory Challenges Read More
WEST CHESTER, PA — In a significant development for Verrica Pharmaceuticals Inc. (Nasdaq: VRCA), the company announced its lead dermatological product, YCANTH™, has been granted New Chemical Entity (NCE) Status …
Verrica Pharmaceuticals Secures Key FDA Designation for YCANTH, Enhancing Market Protection Read More
EXTON, PA — Melior Discovery, Inc., a standout in the pre-clinical pharmacology sector, has been lauded as the Contract Research Organization (CRO) of the Year by Life Sciences Review magazine. …
Melior Discovery Earns Prestigious ‘CRO of the Year’ Title from Life Sciences Review Read More
BERWYN, PA — Nordic Pharma, Inc., a subsidiary of the international healthcare company Nordic Group B.V., has announced the latest addition to its U.S. Medical Advisory Board (MAB)—John P. Fezza, …
Nordic Pharma Welcomes Esteemed Oculoplastic Surgeon to Medical Advisory Board Ahead of Dry Eye Therapy Launch Read More
MALVERN, PA — Venatorx Pharmaceuticals recently announced the addition of three seasoned executives to its senior team, signaling a significant pivot from its core research and development focus towards a …
Venatorx Pharmaceuticals Bolsters Leadership Team Amid Commercialization Push Read More